TABLE 2.
CGB5 | CGB8 | |||||
---|---|---|---|---|---|---|
Full regiona | 5′upstream regionb | Genic regionc | Full regiona | 5′upstream regionb | Genic regionc | |
No of SNPs | 46 | 17 | 29 | 23 | 3 | 20 |
Fertile women | ||||||
Diversity (π)d | 0.00193 | 0.00271 | 0.00169 | 0.00119 | 0.00201 | 0.00095 |
Tajima De | -1.12980 | -1.16944 | -0.88132 | -0.35277 | 2.29389 * | -0.96141 |
P-value of Ewens-Watterson F statisticf | ns | ns | ns | ns | 0.007 | ns |
RM Patients | ||||||
Diversity (π)d | 0.00172 | 0.00195 | 0.0016 | 0.00115 | 0.00199 | 0.0009 |
Tajima De | -1.23744 | -1.23550 | -0.91052 | -0.56306 | 1.26879 | -1.06361 |
P-value of Ewens-Watterson F statisticf | ns | ns | ns | ns | ns | ns |
SNPs in 5′upstream and genic regions
SNPs located in the region of −435 bp up to −1 bp from the start site of mRNA sequence
SNPs located in mRNA seqence: +1 bp up to +1082 bp from the start site of mRNA sequence
Estimate of nucleotide diversity (π) per basepair from average pairwise differences among individuals
The basis of the Tajima’s D statistics (DT) is the difference between observed (π) and expected (θ) diversity estimates: under neutral conditions π = θ and DT = 0
This statistic tests the observed allele frequency spectrum with the expected allele frequency spectrum under the neutral model (Hardy-Weinberg Equilibrium).
p=0.0169; ns - non-significant (p>0.05)